Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    18768369 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Adjuvant Tamoxifen Compared With Anastrozole in Treating Postmenopausal Women With Ductal Carcinoma In Situ
Condition: Breast Cancer
Interventions: Drug: tamoxifen citrate;   Drug: Anastrozole

Indicates status has not been verified in more than two years